加载中
NASDAQHealthcareMedical - Instruments & Supplies
最新数据
US$4.055
+US$0.245 · +6.43%
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
常规交易时段
US$4.055
+US$0.245 · +6.43%
盘中时间采用ET。市场数据可能有所延迟。
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
日内区间
当前US$4.055
52周区间
当前US$4.055
盘中时间采用ET。市场数据可能有所延迟。
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
日内区间
当前US$4.055
52周区间
当前US$4.055
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1142.1万 USD | 868.8万 USD | 408.9万 USD | 204.8万 USD | 155.1万 USD |
| 销货成本 | 691.2万 USD | 594万 USD | 371.5万 USD | 179.2万 USD | 154.3万 USD |
| 毛利 | 450.9万 USD | 274.8万 USD | 37.4万 USD | 25.6万 USD | 8000 USD |
| 研究与开发 | 2000 USD | 7.8万 USD | 10.3万 USD | 36.7万 USD | 3.1万 USD |
| 销售、一般及管理费用 | 785.9万 USD | 591.1万 USD | 339.8万 USD | 281.6万 USD | 240.5万 USD |
| 营业费用 | 786.1万 USD | 630.2万 USD | 385.1万 USD | 360.4万 USD | 257.8万 USD |
| 利息支出 | 3.4万 USD | 8.1万 USD | 1.5万 USD | 133.6万 USD | 199.8万 USD |
| 折旧和摊销 | 74万 USD | 48万 USD | 44.3万 USD | 30.1万 USD | 11.3万 USD |
| 营业利润 | −335.2万 USD | −355.4万 USD | −347.7万 USD | −334.8万 USD | −257万 USD |
| 净利润 | −300万 USD | −328.1万 USD | −315.7万 USD | −474.6万 USD | −431万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
